Kingsberg SA et al., 2019 – To evaluate the safety and efficacy of bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder.
Category: Treatment
A randomized trial comparing group mindfulness-based cognitive therapy with group supportive sex education and therapy for the treatment of female sexual interest/arousal disorder
Brotto LA et al., 2021 –
A group of Canadian researchers, led by Dr. Lori Brotto of the University of British Columbia, were interested in whether group therapies could benefit women with low sexual desire and/or arousal and distress, and if it could last longer term (6-12 months).
A group of Canadian researchers, led by Dr. Lori Brotto of the University of British Columbia, were interested in whether group therapies could benefit women with low sexual desire and/or arousal and distress, and if it could last longer term (6-12 months).
The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder
Kingsberg SA, Clayton AH and Pfaus JG, 2015 – New studies suggest that healthy female sexual function relies on the interaction of both the body and the brain. Various brain pathways and associated neurochemicals are involved in the rewards associated with sexual activity, as well as the excitement and inhibition of sexual responses.
Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials
Tuiten A. et al., 2008 – Effective treatments for physical symptoms of sexual dysfunction have been available since the late 1990s for men, but there are limited treatment options for women. This study describes clinical trials conducted to test out two new products for the treatment of sexual dysfunction in women.